Gilna to Captain CAMERA


By John Russell Bio-IT World

Later this summer, coinciding with the publication of the first peer-reviewed paper on results from J. Craig Venter’s worldwide voyage sampling ocean genomes, researchers will gain access to version 0.5 of CAMERA—the Community Cyberinfrastructure for Advanced Marine Microbial Ecology Research and Analysis—a platform replete with a wealth of data, analysis tools, and high-speed computational infrastructure.

“We’ll point readers to the portal from the paper,” says Paul Gilna, who was appointed executive director of CAMERA last month. Gilna is an experienced science program administrator who helped launch GenBank, worked on the protein data bank (PDB), and was a director of DOE’s Joint Genome Institute at Los Alamos National Laboratory. He hopes CAMERA will help jumpstart and grow the nascent field of metagenomics.

“I’ve noticed it’s one of those fields that’s beginning to take on the ‘in-the-eye-of-the-beholder definition,’ says Gilna. Broadly, metagenomics has been used two ways: One refers to the sequencing of microbial communities that contain large mixtures of microbial species; the other is the capture of data associated with any given microbe or microbial sequence or microbial genome. CAMERA will emphasize the latter, says Gilna, as pure sequence data will also submitted to GenBank, but its metadata will also be housed at CAMERA.

“When we lift a sample out of soils or out of the ocean, we know we are sequencing parts of many thousands, even millions of microbes,” Gilna says. “So for any one sequence, getting the context of what was around it at the time in terms of other sequences is important. In the case of genome sequences garnered from the ocean surveys, there is information associated with spatial location such as GPS coordinates as well as satellite imagery of the particular sites. There are data associated with ocean conditions such as depth, temperature, salinity.”

Soon, scientists may have those data at their finger tips. CAMERA is a partnership among the J. Craig Venter Institute (JCVI), the California Institute for Telecommunications and Information Technology (Calit2), UCSD’s Center for Earth Observation and Applications based at the Scripps Institution of Oceanography, and the San Diego Supercomputer Center.

JCVI is providing data and analysis and visualization tools. Calit2 is providing computational infrastructure, based on its high-performance optical networked computing system known as OptIPuter (which is building on a national high-speed 10-gigabit grid). Funding of $24.5 million, over seven years, comes from the Gordon and Betty Moore Foundation, which also partly funded Venter’s ocean genome sampling project.

“Phase one, which we sort of term the sprint phase, is to really get the system up and running, knowing what we do today. The second phase, which we’ve characterized as the marathon, is one in which the facilities we offer, the tools that we offer, will in large part be defined by the community itself. We know our assembled partnership here can say and posit a lot of what could be done to harness this new data set, but part of what we need to do is engage with the community,” says Gilna.

In fact, a key CAMERA goal, says its new boss, is to create a platform on which members of the community can not only develop needed tools but also use that same platform to provide them to the community at large.

The project began in earnest in February, and Gilna says a series of release cycles has already been planned. Roughly 30 people are working full time at JCVI on the project, and a similar number in San Diego are engaged in the day-to-day project management of getting the first release in place to coincide with publication of the papers. Gilna didn’t specify which journal, but said the June-July timeframe was likely.

“If you look at GenBank, which is where I really started this career, I came to Los Alamos in 1988 to join the project. The growth of data at the time had clearly begun to demonstrate an exponential growth pattern, when in fact at the project’s initiation everybody believed, certainly the funders, that the growth rate would at best be linear,” says Gilna.

He expects CAMERA to experience the same sort of explosive data influx and to produce a great deal of fundamental science such as was hinted at by the Venter proof-of-concept sequencing effort in the Sargasso Sea in which he reported finding 70,000 entirely novel genes, from an estimated 1,800 genomic species, including 148 novel bacterial phylotypes (see Venter Makes Waves—Again, April 2004 Bio-IT World, page 1).

Turning the bicoastal effort into a cohesive team will require both advanced technology (“state-of-the-art videoconferencing”) and surmounting cultural challenges, agrees Gilna, whose “line of sight” bosses include Larry Smarr, director of Calit2, and Ramesh Rao, USCD division director of Calit2. No doubt Venter will share his opinions with the new director.

“This is a huge and welcome challenge for me,” says Gilna. “I’ve sort of known these people throughout my career in one way or another. I’m most energized when I’m working on projects where success or failure is judged by how well the community believes it has been served.” If the past is prologue, CAMERA is likely in good hands.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.





For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.